What is the best evidence for determining harms of medical treatment?
作者信息
Vandenbroucke Jan P
机构信息
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
出版信息
CMAJ. 2006 Feb 28;174(5):645-6. doi: 10.1503/cmaj.051484.
Abstract
摘要
相似文献
1
What is the best evidence for determining harms of medical treatment?确定医疗危害的最佳证据是什么？
CMAJ. 2006 Feb 28;174(5):645-6. doi: 10.1503/cmaj.051484.
2
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.随机研究与非随机研究中医疗干预危害证据的比较。
CMAJ. 2006 Feb 28;174(5):635-41. doi: 10.1503/cmaj.050873.
3
Controversy over "contradiction": Should randomized trials always trump observational studies?关于“矛盾”的争议：随机试验是否应始终胜过观察性研究？
Am J Ophthalmol. 2009 Mar;147(3):384-6. doi: 10.1016/j.ajo.2008.04.024.
4
Re: Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.关于：干预措施的荟萃分析除了随机对照试验外是否应纳入观察性研究？对基本原则的批判性审视。
Am J Epidemiol. 2009 Mar 15;169(6):783; author reply 783-4. doi: 10.1093/aje/kwp016. Epub 2009 Feb 10.
5
[Epidemiology versus clinical trial. A five-round-match on scientific reliability].
Lakartidningen. 2002 Jul 25;99(30-31):3132-4.
6
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study.哪些临床研究能提供最佳证据？最佳的随机对照试验仍然胜过最佳的观察性研究。
BMJ. 2000 Jul 29;321(7256):255-6. doi: 10.1136/bmj.321.7256.255.
7
From observational studies to randomized trials: asking the right question at the right time.
J Clin Periodontol. 2006 Aug;33(8):517-9. doi: 10.1111/j.1600-051X.2006.00970.x.
8
Randomized controlled studies: scientific evidence or disinformation?随机对照研究：科学证据还是虚假信息？
Scand Cardiovasc J. 2011 Jun;45(3):131-2. doi: 10.3109/14647273.2011.564753. Epub 2011 Mar 9.
9
Evidence for Health Decision Making - Beyond Randomized, Controlled Trials.健康决策的证据——超越随机对照试验
N Engl J Med. 2017 Aug 3;377(5):465-475. doi: 10.1056/NEJMra1614394.
10
Identifying the least biased studies.识别偏差最小的研究。
Prescrire Int. 2015 Apr;24(159):102.
引用本文的文献
1
Safety outcome trials in four mainline medical journals 30 years apart: a narrative review and the need for the transparency of informed consents.相隔30年的四大主流医学期刊中的安全性结果试验：一篇叙述性综述及对知情同意透明度的需求
Trials. 2025 Jan 25;26(1):28. doi: 10.1186/s13063-025-08732-x.
2
The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.文拉法辛治疗成人重性抑郁障碍的不良事件风险：系统评价随机临床试验的Meta 分析和试验序贯分析。
Epidemiol Psychiatr Sci. 2024 Oct 23;33:e51. doi: 10.1017/S2045796024000520.
3
Effectiveness of zygomatic-implant fixed rehabilitation for the atrophic edentulous maxilla: protocol for a systematic review and network meta-analysis.颧骨种植体固定修复治疗萎缩性无牙颌的效果：系统评价和网络荟萃分析方案。
Syst Rev. 2024 May 31;13(1):146. doi: 10.1186/s13643-024-02561-w.
4
Effects of regional anaesthesia on mortality in patients undergoing lower extremity amputation: A retrospective pooled analysis.区域麻醉对接受下肢截肢手术患者死亡率的影响：一项回顾性汇总分析。
Indian J Anaesth. 2022 Jun;66(6):419-430. doi: 10.4103/ija.ija_917_21. Epub 2022 Jun 21.
5
Defining and measuring meditation-related adverse effects in mindfulness-based programs.界定和衡量基于正念的项目中与冥想相关的不良影响。
Clin Psychol Sci. 2021 May 18;9(6):1185-1204. doi: 10.1177/2167702621996340. Epub 2021 Nov 1.
6
Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.英国一项针对 12 至 15 岁持续性性别焦虑青少年的选择队列研究：青春期抑制的短期结果。
PLoS One. 2021 Feb 2;16(2):e0243894. doi: 10.1371/journal.pone.0243894. eCollection 2021.
7
Ranking evidence in substance use and addiction.物质使用与成瘾方面的证据分级
Int J Drug Policy. 2020 Sep;83:102840. doi: 10.1016/j.drugpo.2020.102840. Epub 2020 Jul 6.
8
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.他汀类药物对75岁及以上人群心血管疾病一级预防的净效益：一项效益-危害平衡建模研究。
Ther Adv Chronic Dis. 2019 Sep 25;10:2040622319877745. doi: 10.1177/2040622319877745. eCollection 2019.
9
Side effects of corticosteroids in patients with advanced cancer: a systematic review.晚期癌症患者使用皮质类固醇的副作用：系统评价。
Support Care Cancer. 2018 Dec;26(12):3979-3983. doi: 10.1007/s00520-018-4339-2. Epub 2018 Jul 6.
10
Safety of psychotropic medicines: contribution from observational evidence.精神药物的安全性：来自观察性证据的贡献。
Epidemiol Psychiatr Sci. 2018 Dec;27(6):531-536. doi: 10.1017/S2045796018000276. Epub 2018 May 30.
本文引用的文献
1
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.随机研究与非随机研究中医疗干预危害证据的比较。
CMAJ. 2006 Feb 28;174(5):635-41. doi: 10.1503/cmaj.050873.
2
The road to health care.医疗保健之路。
BMJ. 2004 Jul 3;329(7456):1-2. doi: 10.1136/bmj.329.7456.1.
3
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.结合马雌激素与绝经后女性可能患痴呆症和轻度认知障碍的发生率：女性健康倡议记忆研究
JAMA. 2004 Jun 23;291(24):2947-58. doi: 10.1001/jama.291.24.2947.
4
When are observational studies as credible as randomised trials?观察性研究何时能与随机试验一样可信？
Lancet. 2004 May 22;363(9422):1728-31. doi: 10.1016/S0140-6736(04)16261-2.
5
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone.在评估胺碘酮不良反应发生率时三种不同数据来源的比较。
Br J Clin Pharmacol. 2004 May;57(5):616-21. doi: 10.1111/j.0306-5251.2003.02055.x.
6
Assessing the quality of research.评估研究质量。
BMJ. 2004 Jan 3;328(7430):39-41. doi: 10.1136/bmj.328.7430.39.
7
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.罗非昔布或萘普生与安慰剂对阿尔茨海默病进展的影响：一项随机对照试验。
JAMA. 2003 Jun 4;289(21):2819-26. doi: 10.1001/jama.289.21.2819.
8
Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.乳腺癌放疗后10年以上的心血管疾病死亡率：对90000名瑞典女性的全国队列研究
BMJ. 2003 Feb 1;326(7383):256-7. doi: 10.1136/bmj.326.7383.256.
9
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.普伐他汀用于有血管疾病风险的老年人（PROSPER）：一项随机对照试验。
Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x.
10
Improving safety reporting from randomised trials.提高随机试验的安全性报告。
Drug Saf. 2002;25(2):77-84. doi: 10.2165/00002018-200225020-00002.
Zotero 插件